IDEXX Laboratories, Inc.
IDXX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $888 | $845 | $679 | $745 |
| Dep. & Amort. | $130 | $115 | $112 | $105 |
| Deferred Tax | -$24 | -$48 | -$35 | -$3 |
| Stock-Based Comp. | $60 | $60 | $50 | $38 |
| Change in WC | -$133 | -$72 | -$274 | -$138 |
| Other Non-Cash | $8 | $8 | $11 | $9 |
| Operating Cash Flow | $929 | $907 | $543 | $756 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$121 | -$134 | -$149 | -$120 |
| Net Acquisitions | -$78 | $0 | -$47 | -$173 |
| Inv. Purchases | $0 | $0 | -$25 | $0 |
| Inv. Sales/Matur. | $2 | $0 | $72 | $0 |
| Other Inv. Act. | -$10 | $8 | -$47 | $0 |
| Investing Cash Flow | -$207 | -$125 | -$195 | -$293 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$75 | -$404 | $431 | $24 |
| Stock Issued | $44 | $47 | $36 | $47 |
| Stock Repurch. | -$837 | -$72 | -$820 | -$747 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$11 | -$13 | -$17 | -$21 |
| Financing Cash Flow | -$878 | -$442 | -$371 | -$697 |
| Forex Effect | -$10 | $2 | -$9 | -$5 |
| Net Chg. in Cash | -$166 | $341 | -$32 | -$239 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $454 | $113 | $144 | $384 |
| End Cash | $288 | $454 | $113 | $144 |
| Free Cash Flow | $798 | $773 | $394 | $636 |